# HERZUMA

NDC: 63459-303
Generic name: TRASTUZUMAB
Labeler / Manufacturer: Cephalon, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20200316

FDA application: BLA761091

## Active ingredients

- TRASTUZUMAB: 150 mg/7.15mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63459-303"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63459-303
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ae71c003-883a-4cd8-ad50-e8cc9a54e971